CAS: 954126-98-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | DANIRIXIN REF: IN-DA01DGJ4CAS: 954126-98-8 | 97% | 56.00 €~625.00 € | Tue 21 Jan 25 |
 | Danirixin REF: TM-T5193CAS: 954126-98-8 | 100.00% - 99.78% | 60.00 €~2,166.00 € | Mon 27 Jan 25 |
 | Danirixin (GSK1325756) REF: 4Z-K-031085CAS: 954126-98-8 | - - - | To inquire | Mon 27 Jan 25 |
 | Danirixin (GSK1325756) REF: 3D-ENB12698CAS: 954126-98-8 | Min. 95% | - - - | Discontinued product |
DANIRIXIN
CAS:954126-98-8
Formula:
C19H21ClFN3O4S
Purity:
97%
Color and Shape:
Solid
Molecular weight:
441.9041
Ref: IN-DA01DGJ4
| 1mg | 56.00 € | ||
| 5mg | 111.00 € | ||
| 10mg | 165.00 € | ||
| 25mg | 199.00 € | ||
| 100mg | 625.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Danirixin
CAS:954126-98-8
Danirixin (GSK1325756) is a potent antagonist of CXCR2 that inhibits IL-8 binding to CXCR2 (IC50: …
Formula:
C19H21ClFN3O4S
Purity:
100.00% - 99.78%
Color and Shape:
Solid
Molecular weight:
441.9
Ref: TM-T5193
| 1mg | 60.00 € | ||
| 5mg | 109.00 € | ||
| 10mg | 176.00 € | ||
| 25mg | 328.00 € | ||
| 50mg | 522.00 € | ||
| 100mg | 736.00 € | ||
| 1mL*10mM (DMSO) | 133.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
Ref: 4Z-K-031085
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
Danirixin (GSK1325756)
CAS:954126-98-8
Danirixin is a small molecule drug that has been shown to inhibit the activity of …
Formula:
C19H21ClFN3O4S
Purity:
Min. 95%
Molecular weight:
441.9 g/mol
Ref: 3D-ENB12698
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
